In the newly formed Center for Arrhythmia Research, teams of interdisciplinary clinicians and scientists will work together to discover both the underlying molecular causes of arrhythmias and new standards of care for their treatment.
Northwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
A novel heart failure drug called sacubitril-valsartan reduced the risk of hospitalizations for heart failure and death from cardiovascular causes more in women than in men, according to a study published in Circulation.
High levels of albumin — the most abundant protein in the bloodstream — present in one’s urine may indicate a higher risk of heart failure later in life, according to a study published in JAMA Cardiology.
A new study published previously unknown details about the lineage of lymphatic endothelial cells associated with the heart.
Listen to a selection of the most popular episodes of the Breakthroughs podcast series produced in 2019, including a possible Amish fountain of youth, artificial intelligence, the rise of food allergies and more.
Measuring atrial fibrillation through implanted devices like pacemakers can identify patients at risk for stroke, according to a recent study.
Ramael Ohiomoba, a second-year student, was one of two medical students in the country to be awarded the Dr. Richard Allen Williams Scholarship through the Association of Black Cardiologists.
A drug originally designed to help manage diabetes may also improve quality of life for patients with heart failure, according to a recent clinical trial.
A new Northwestern Medicine study found an experimental drug did not lower hospitalization among patients suffering from heart failure with preserved ejection fraction.